MHTX Stock Overview
A technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Manhattan Scientifics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0008 |
| 52 Week High | US$0.0052 |
| 52 Week Low | US$0.0004 |
| Beta | 1.29 |
| 11 Month Change | -20.00% |
| 3 Month Change | -27.27% |
| 1 Year Change | -78.67% |
| 33 Year Change | -96.44% |
| 5 Year Change | -94.84% |
| Change since IPO | -92.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MHTX | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | 0.5% |
| 1Y | -78.7% | 15.6% | 30.7% |
Return vs Industry: MHTX underperformed the US Biotechs industry which returned 15.6% over the past year.
Return vs Market: MHTX underperformed the US Market which returned 30.7% over the past year.
Price Volatility
| MHTX volatility | |
|---|---|
| MHTX Average Weekly Movement | 29.1% |
| Biotechs Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MHTX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MHTX's weekly volatility has decreased from 43% to 29% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Manny Tsoupanarias | mhtx.com |
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications.
Manhattan Scientifics, Inc. Fundamentals Summary
| MHTX fundamental statistics | |
|---|---|
| Market cap | US$447.42k |
| Earnings (TTM) | -US$1.06m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.4x
P/E RatioIs MHTX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MHTX income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$1.06m |
| Earnings | -US$1.06m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -2.6% |
How did MHTX perform over the long term?
See historical performance and comparison